[abstract] FACTORS INFLUENCING PHYSICIAN ADOPTION OF HYPERBARIC OXYGEN THERAPY IN WOUND CARE

Rubicon Research Repository/Manakin Repository

[abstract] FACTORS INFLUENCING PHYSICIAN ADOPTION OF HYPERBARIC OXYGEN THERAPY IN WOUND CARE

Show full item record


Title: [abstract] FACTORS INFLUENCING PHYSICIAN ADOPTION OF HYPERBARIC OXYGEN THERAPY IN WOUND CARE
Author: Guo, S; Counte, MA; Schmitz, H
Abstract: BACKGROUND: Although evidence has been growing to support the application of hyperbaric oxygen (HBO2) therapy in the treatment of chronic wounds, the adoption of this therapy seems to be still limited. This study aimed to identify factors that are associated with physician adoption of HBO2 therapy in wound care. METHODS: A questionnaire containing 23 items that assessed physician characteristics, physician knowledge of and attitudes toward HBO therapy, and institutional factors was developed based on Rogers' diffusion of innovation framework. It was pretested with 10 physicians in the field of hyperbaric medicine and wound care and then distributed to 609 physicians who received board certification before December 1, 2001 from the American Academy of Wound Management. Multiple logistic regression, using a significance level of p=.05, was employed to identify factors that are associated with the adoption of HBO2 therapy. RESULTS: Among all the factors examined, only four factors were found to be significantly associated with physician adoption of HBO2 therapy in wound care. They are 1) voluntary patient request of HBO2 therapy (adjusted OR = 6.23, 95percentCI = 2.59 - 14.97), 2) positive attitude toward HBO2 therapy (adjusted OR = 3.17, 95percentCI = 1.29-7.78), 3) high level of familiarity with HBO2 therapy (adjusted OR = 7.57, 95percentCI = 2.11 - 27.16), and 4) practice location in either Florida or Texas (adjusted OR = 7.31, 95percentCI = 1.81 - 29.42). CONCLUSION: Findings from this study will help those interested parties to develop effective dissemination strategies to facilitate the diffusion of HBO2 therapy. Future study should focus on understanding the underlying reasons that cause the differences in the adoption of HBO2 therapy among regions.
Description: Undersea and Hyperbaric Medical Society, Inc. (http://www.uhms.org )
URI: http://archive.rubicon-foundation.org/1473
Date: 2004

Files in this item

Files Size Format View
abstract.txt 259bytes Text file View/Open

This item appears in the following Collection(s)

  • UHMS Meeting Abstracts
    This is a collection of the published abstracts from the Undersea and Hyperbaric Medical Society (UHMS) annual meetings.

Show full item record

Browse

My Account